The pandemic’s challenge to evidence-based medicine shows off-label use is an important tool
In 2020, the medical and research communities have scrambled towards finding an effective intervention against the novel coronavirus, COVID-19. And in lieu of data from randomised controlled trials (RCTs) of interventions against the disease (considered the gold standard of evidence), clinicians wer…